Summary

Location
at La Jolla, California and other locations
Dates
study started
completion around

Description

Summary

This study collects blood samples, medical information, and medical images from patients who are being treated for cancer and have a positive test for SARS CoV-2, the new coronavirus that causes the disease called COVID-19. Collecting blood samples, medical information, and medical images may help researchers determine how COVID-19 affects the outcomes of patients undergoing cancer treatment and how having cancer affects COVID-19.

Official Title

NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study

Details

Keywords

COVID-19 Infection, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, COVID-19, Neoplasms, Biospecimen Collection, Data Collection, Quality-of-Life Assessment

Eligibility

Locations

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
National Cancer Institute (NCI)
Links
Select individual patient-level data from this trial can be requested from the NCTN/NCORP Data Archive.
ID
NCT04387656
Study Type
Observational
Participants
About 1877 people participating
Last Updated